CD28 Emerges as a CAR T Target in T Cell Malignancies

Company LMU Munich; University of Freiburg (academic) Event Type Peer-reviewed preclinical study (Nature Communications) Modality CRISPR-edited CAR-T (CD28 knockout) Asset Anti-CD28 CAR-T constructs Target CD28 Disease Area T-cell acute lymphoblastic leukemia; selected T-cell lymphomas Summary A peer-reviewed Nature Communications study from LMU Munich, the University…